Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Org-36286 enters phase III in treatment of infertility

July 27, 2006

Antares Pharma and Population Council to develop topical Nestorone product

July 26, 2006

Nektar receives payment under Affymax partnership

July 26, 2006

Oscient to acquire Antara U.S. rights

July 26, 2006

TPM-02/Insulin studied in phase I trial

July 26, 2006

Elaprase approved for Hunter's syndrome

July 25, 2006

Lilly and Alcon sign marketing collaboration for Arxxant

July 25, 2006

Phase III begins for Actos + TAK-536 combination product

July 25, 2006

Ostarine phase II proof-of-concept study completes enrollment

July 25, 2006

Pfizer begins Exubera introduction with education and training program

July 25, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...